MBF: Prosthesis, Shoulder, Semi-Constrained, Metal/Polymer, Uncemented

Product code MBF, “Prosthesis, Shoulder, Semi-Constrained, Metal/Polymer, Uncemented” in FDA's classification database, is a Class II device type under 21 CFR 888.3670 (shoulder joint metal/polymer/metal nonconstrained or semi-constrained porous-coated uncemented prosthesis), reviewed by FDA's Orthopedic panel. FDA's 510(k) database lists 37 clearances under MBF, 25 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
MBF
Regulation
21 CFR 888.3670
Class
II
Panel
Orthopedic
Clearances
37
Most recent
Apr 13, 2026
Median review, last 2 years
123 days
Third-party review
Not eligible
Implant
Yes

What it covers

A shoulder joint metal/polymer/metal nonconstrained or semi-constrained porous-coated uncemented prosthesis is a device intended to be implanted to replace a shoulder joint. The device limits movement in one or more planes. It has no linkage across-the-joint. This generic type of device includes prostheses that have a humeral component made of alloys such as cobalt-chromium-molybdenum (Co-Cr-Mo) and titanium-aluminum-vanadium (Ti-6Al-4V) alloys, and a glenoid resurfacing component made of ultra-high molecular weight polyethylene, or a combination of an articulating ultra-high molecular weight bearing surface fixed in a metal shell made of alloys such as Co-Cr-Mo and Ti-6Al-4V. The humeral component and glenoid backing have a porous coating made of, in the case of Co-Cr-Mo components, beads of the same alloy or commercially pure titanium powder, and in the case of Ti-6Al-4V components, beads or fibers of commercially pure titanium or Ti-6Al-4V alloy, or commercially pure titanium powder. The porous coating has a volume porosity between 30 and 70 percent, an average pore size between 100 and 1,000 microns, interconnecting porosity, and a porous coating thickness between 500 and 1,500 microns. This generic type of device is designed to achieve biological fixation to bone without the use of bone cement.

The identification in 21 CFR 888.3670, shoulder joint metal/polymer/metal nonconstrained or semi-constrained porous-coated uncemented prosthesis. FDA gives MBF no definition of its own, so the regulation’s describes it.

FDA flags MBF devices as implants.

Recent clearances

510(k)DeviceApplicantDecisionType
K253592Zimmer Biomet Reverse Shoulder Prosthesis (Alliance Humeral Bearings, Identity Humeral Trays, Comprehensive Reverse Humeral Trays, Comprehensive Reverse 32mm Glenospheres and Adapter)Zimmer, Inc.Apr 13, 2026Traditional
K251098Identity Revision Humeral StemsZimmer, Inc.Aug 11, 2025Traditional
K250848Identity Shoulder SystemZimmer, Inc.Jul 2, 2025Traditional
K240876Identity Shoulder SystemZimmer, Inc.Jun 12, 2024Traditional
K233712PRIMA Humeral System; PRIMA TT GlenoidLima Corporate S.P.A.Jan 11, 2024Traditional
K231099SMR Hybrid Glenoid SystemLima Corporate S.P.A.Dec 21, 2023Traditional
K230831INHANCE Shoulder System Convertible Glenoid Inserts, INHANCE Convertible GlenoidDepuy Ireland UCNov 13, 2023Traditional
K231516INHANCE™ Shoulder System, Sterile Single Use InstrumentationDepuy Ireland UCJul 21, 2023Traditional
K223876SMR Shoulder SystemLima Corporate S.P.A.Feb 3, 2023Traditional
K222427PRIMA TT GlenoidLima Corporate S.P.A.Oct 6, 2022Traditional
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 37 with a free account)

Clearances by year

25 MBF 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
2026 (so far)1147
20252114
2024264
20234144
20224164
20211245
20202262
2019256
20181309
20172232
20141208
20131201
20122132

Who submits

10 applicants cleared a MBF device since 2011. 52% of the clearances went to applicants in United States, then Italy (32%), Ireland (12%) and France (4%). By type: Traditional 96% and Special 4%.

ApplicantClearances since 2011
Lima Corporate S.P.A.8
Zimmer, Inc.5
Depuy Ireland UC3
Biomet Manufacturing Corp2
Biomet, Inc.2
Biomet Manufactuting Corp.1
Biomet Orthopedics, LLC1
Fournitures Hospitalieres Industrie1

How FDA classifies it

Class II (special controls). The special control for this device is FDA's “Class II Special Controls Guidance: Shoulder Joint Metal/Polymer/Metal Nonconstrained or Semi-Constrained Porous-Coated Uncemented Prosthesis.”

From 21 CFR 888.3670. Special controls are the requirements a 510(k) must show it meets.

Standards

21 CFR 888.3670 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent MBF clearances declared.

Ask about MBF

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about MBF

What is FDA product code MBF?

Product code MBF, “Prosthesis, Shoulder, Semi-Constrained, Metal/Polymer, Uncemented” in FDA's classification database, is a Class II device type under 21 CFR 888.3670 (shoulder joint metal/polymer/metal nonconstrained or semi-constrained porous-coated uncemented prosthesis), reviewed by FDA's Orthopedic panel. FDA's 510(k) database lists 37 clearances under MBF, 25 of them since 2011.

How many 510(k) clearances are there under MBF?

FDA’s 510(k) database listed 37 clearances under MBF as of Oct 29, 2026, 25 of them decided since 2011; the most recent decision was Apr 13, 2026. The Predicate Finder searches the live database.

How long does FDA take to clear a MBF 510(k)?

For the 3 MBF clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 123 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most MBF clearances?

Since 2011: Lima Corporate S.P.A. (8), Zimmer, Inc. (5), Depuy Ireland UC (3), Biomet Manufacturing Corp (2) and Biomet, Inc. (2). 10 applicants have cleared a MBF device in that time.

Sources

  1. FDA product classification: MBF · Product Classification database
  2. 21 CFR 888.3670: Shoulder joint metal/polymer/metal nonconstrained or semi-constrained porous-coated uncemented prosthesis · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for MBF · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow MBFGet an email when FDA clears, recalls or publishes guidance for MBF devices.

Know what FDA already cleared.